¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acetic acid reaction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • conversion reaction
    Àüȯ¹ÝÀÀ
  • counter reaction
    ¿ª¹ÝÀÀ
  • coupled reaction
    °ø¿ª¹ÝÀÀ, ¦Áø¹ÝÀÀ, ¿¬°á¹ÝÀÀ
  • cross-reaction
    ±³Â÷¹ÝÀÀ
  • cutaneous drug reaction
    ÇǺξ๰¹ÝÀÀ
  • cutaneous reaction
    ÇǺιÝÀÀ
  • cytotoxic reaction
    ¼¼Æ÷µ¶¼º¹ÝÀÀ
  • cascade reaction
    ¿¬¼Ó´Ü°è¹ÝÀÀ
  • catalytic reaction
    Ã˸ŹÝÀÀ
  • catastrophic reaction
    ÆÄ±¹¹ÝÀÀ
  • cell-mediated reaction
    ¼¼Æ÷¸Å°³¹ÝÀÀ
  • calcium-catalyzed reaction
    Ä®½·Ã˸ŹÝÀÀ
  • cessation reaction
    Á¤Áö¹ÝÀÀ
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • downgrading reaction
    ÇÏÇâ¹ÝÀÀ
  • dry reaction
    °Ç½Ä¹ÝÀÀ
  • early reaction
    Á¶±â¹ÝÀÀ
  • elementary reaction
    ±âº»¹ÝÀÀ
  • elevator reaction
    ½Â°­¹ÝÀÀ
  • emergency reaction
    ±ä±Þ¹ÝÀÀ
  • endergonic reaction
    ¿¡³ÊÁöÈí¼ö¹ÝÀÀ
  • endothermic reaction
    Èí¿­¹ÝÀÀ
  • enzyme-antienzyme reaction
    È¿¼ÒÇ×È¿¼Ò¹ÝÀÀ
  • eosinophilic leukemoid reaction
    È£»ê±¸¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • equilibrium reaction
    ÆòÇü¹ÝÀÀ
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ
  • escape reaction
    µµÇǹÝÀÀ
  • exergonic reaction
    ¹ß¿­¹ÝÀÀ, ¿¡³ÊÁö¹æÃâ¹ÝÀÀ
  • exoergic reaction
    ¿ÜÀιÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • acid springs
    »ê¼ºÃµ(Ë×ËÛ̧).
  • acid sterile pyuria
    »ê¼º¹«±Õ³ó´¢
  • acid tide
    »êÁõ°¡±â.
  • acid value
    »ê°ª, »ê°¡(߫ʤ).
  • acid, dipicolinic
    µðÇÇÄݸ°»ê
  • acid, lipoteichoic
    ÁöÁúŸÀÌÄÚ»ê
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acid, muramic
    ¹Â¶ó¹Í»ê
  • acid, teichoic
    ŸÀÌÄÚ»ê
  • acid, teichuronic
    ŸÀÌÅ¥·Ð»ê
  • acid, ¥â-hydroxymyristic
    º£Å¸ÇÏÀ̵å·Ï½Ã¹Ì¸®½ºÆ¾»ê
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • acid-base compensation
    »ê¿°±â º¸»ó
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à
  • acid-fast bacillus
    Ç×»ê±Õ(ù÷߫ж)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • motor reaction
    ¿îµ¿ ¹ÝÀÀ(¡­Úãëë).
  • myasthenic reaction
    ±Ù¹«·ÂÁõ¹ÝÀÀ.
  • myelooxidase reaction
    ¹Ì¿¤·Î¿Á½Ã´ÙÁ¦¹ÝÀÀ(¡­Úãëë).
  • myotonic reaction
    ±Ù±äÀ强 ¹ÝÀÀ(¡­Úãëë).
  • neurotic reaction (= psychoneurotic r.)
  • neutral reaction
    ÁßÈ­¹ÝÀÀ(~Úãëë).
  • neutrophilic leukemoid reaction
    È£Áß±¸¼º ¹éÇ÷º´¾ç ¹ÝÀÀ
  • ninhydrin reaction
    ´ÑÈ÷µå¸°¹ÝÀÀ(~Úãëë).
  • nitrosoindol reaction
    ´ÏÆ®·ÎÀε¹¹ÝÀÀ(~Úãëë).
  • nociceptive reaction
    Ä§ÇØ¹ÝÀÀ(~Úãëë).
  • nonspecific reaction
    ºñƯÀ̹ÝÀÀ.
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ.
  • orbicular reaction
    Æó°Ë¹ÝÀÀ(øÍÌ¡Úãëë).
  • orcinol reaction
    ¿À¸£½Ã³î ¹ÝÀÀ(¡­Úãëë).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • deoxycytidylic acid
    µ¥¿Á½Ã»çÀÌÆ¼µô»ê(ß«)
  • deoxyguanylic acid
    µ¥¿Á½Ã±¸¾Æ´Ò»ê(ß«)
  • deoxyribonucleic acid
    µ¥¿Á½Ã¶óÀ̺¸ÇÙ»ê(ß«)
  • deoxyribose nucleic acid
    "µ¥¿Á½Ã¶óÀ̺¸½º ÇÙ»ê(ú·ß«), (ÔÒ) deoxyribonucleic acid"
  • deoxythymidylic acid
    "µ¥¿Á½ÃŸÀ̵̹ô»ê(ß«), (ÔÒ) thymidylic acid"
  • deoxyuridylic acid
    µ¥¿Á½ÃÀ¯¸®µô»ê
  • deuridylic acid
    Å»(÷­)À¯¸®µô »ê(ß«)
  • dicarboxylic acid cycle
    "ÀÌ(ì£)Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ), (ÔÒ) glyoxylate cycle"
  • "2,4-dichlorophenoxyacetic acid"
    "2,4-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,6-dichlorophenoxyacetic acid"
    "2,6-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,5-dihydroxyphenylacetic acid"
    "2,5-ÀÌ(ì£)ÇÏÀ̵å·Ï½ÃÆä´Ò¾Æ¼¼Æ®»ê(ß«) (ÔÒ) homogentisic acid"
  • dinitrophenyl amino acid
    ÀÌ(ì£)´ÏÆ®·ÎÆä´Ò ¾Æ¹Ì³ë»ê(ß«)
  • "1,3-diphosphoglyceric acid"
    "1,3-ÀÌÀλê(ì£×òß«)±Û¸®¼¼¸°»ê(ß«), (ÔÒ) 1,3-bisphosphoglycerate"
  • "2,3-diphosphoglyceric acid"
    "2,3-ÀÌÀλê(ì£×òß«)±Û¸®¼¼¸°»ê(ß«), (ÔÒ) 2,3-bisphosphoglycerate"
  • dipicolinic acid
    µðÇÇÄݸ®´Ñ»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
AR absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista...
ARAL adjustment reaction to adult life
ARD absolute reaction of degeneration; acute radiation disease; acute respiratory disease; adult respira...
ARI acute respiratory illness; airway reactivity index; anxiety reaction, intense
ARM adrenergic receptor material; aerosol rebreathing method; ambulatory renal monitor; anorectal manome...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
RT-PCR Reverse Transcription Polymerase Chain Reaction
RT-PCR Reverse transcribed polymerase chain reaction
RT-PCR Reverse transcript polymerase chain reaction
RT-PCR Reverse transcriptase-polymerase chain reaction amplification
RT-PCR Reverse transcription and polymerase chain reaction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • metabolic defect of amino acid
    ¾Æ¹Ì³ë»ê ´ë»ç °áÇÔ
    ¾Ëİſ ´¢Áõ.
  • metaphosphoric acid
    ¸ÞŸÀλê
    ÀλêÀÇ Çϳª. Çü»óÀ¸·Î º¸¾Æ À¯¸®»ó ÀÎ»ê ¶Ç´Â ºù»ó ÀλêÀ̶ó°íµµ ÇÑ´Ù. È­ÇÐ½Ä HPO. ¹Ì»ý¹°, °ïÃæ·ù ¶Ç´Â ¾î¶² Á¾·ùÀÇ µ¿¹°ÀÇ Á¶Á÷ µî¿¡ Á¸ÀçÇÑ´Ù. ¹«»ö Åõ¸íÇÑ À¯¸®»ó °íü ¶Ç´Â ºÎµå·¯¿î ºñ´Ü½Ç ¸ð¾çÀÇ ±«»ó ¹°Áú·Î, ºÐÀÚ·® 79.98, ºñÁß 2.2ÀÌ´Ù. Á¶ÇؼºÀ̸ç, ½ÀÇÑ °ø±â ¼Ó¿¡ ¹æÄ¡ÇÏ¸é ¿À¸£Åä Àλê HPO°¡ µÈ´Ù. ¹°, ¿¡Åº¿Ã¿¡ Àß ³ì´Â´Ù. °¡¿­ÇÏ¸é ¿ëÀ¶ÇÏ¿© Á¡¼ºµµ°¡ Áõ°¡ÇÏ°í ´õ¿í °¡¿­ÇÏ¸é ½ÂÈ­ÇÑ´Ù. ¼ö¿ë¾× ¼Ó¿¡¼­´Â ÁßÇÕü¸¦ Àß ¸¸µé°í, °£´ÜÇÑ °Íµµ »ïÇÕü³ª »çÇÕü°¡ µÇÁö¸¸, Àå½Ã°£ ¹æÄ¡ÇÏ¸é ¿À¸£ÅäÀλêÀ¸·Î º¯ÇÑ´Ù. ¸ÞŸÀÎ»ê ¿ë¾×¿¡ Áú»ê Àº ¿ë¾×À» °¡ÇÏ¸é ¹é»ö ħÀüÀÌ »ý±ä´Ù. ¸ÞŸÀλêÀº ¿À¸£ÅäÀÎ»ê ¶Ç´Â ÇÇ·ÎÀλê HPOÀ» 300 ¡É ÀÌ»óÀ¸·Î °¡¿­ÇÏ¸é »ý±ä´Ù. 2HPO 2j HPO+HO HPO 2j 2HPO+HO ¶Ç ¿À»êÈ­ÀÎÀ» 0 ¡É ÀÌÇÏ·Î ¼öÈ­ÇØµµ ¾ò´Â´Ù. Ä¡°ú¿ë ½Ã¸àÆ® , È­Çкм®¿ë ½Ã¾à, º¸ÀÏ·¯ ûÁ¤Á¦, ÀμâÁ¦ÆÇ, °¡Á×ÀÇ ¹«µÎÁú µî¿¡ ¾²À̸ç, Ä®·ý¿°Àº À¯Á¦Ç°ÀÇ Á¡¼ºµµ Áõ°¡Á¦, ¼¼Á¦, ÇÜ, ¼Ò½ÃÁöÀÇ Ã·°¡Á¦·Î »ç¿ëµÈ´Ù. ¶ÇÇÑ, ¸ÞŸÀλêÀº »ý¹°ÇлóÀ¸·Îµµ ¸Å¿ì Èï¹Ì·Î¿î ¼ºÁúÀ» °¡Áö°í Àִµ¥, È¿¸ð¿¡¼­´Â ÇÙ»êÀÇ ÇÕ¼º¿¡ ÇÊ¿äÇÑ Àΰú ¿¡³ÊÁö¸¦ ¸ÞŸÀλêÀÌ °ø±ÞÇÏ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • methacrylic acid
    ¸ÞŸ ¾ÆÅ©¸¯ »ê
  • morrhuate sodium : °£À¯ÀÇ Áö¹æ»ê ³ªÆ®·ý¿°. °æÈ­Á¦·Î¼­ ƯÈ÷ Á¤¸Æ·ù ¹× Ä¡ÁúÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç Á¤¸Æ·ù ³»·Î ¿ë¾×À» ÁÖ»çÇÑ´Ù.

    morrhuic acid

    ¸ð·çÀλê
  • mucosal barrier to acid back-diffusion

    mucosal bleeding (Á¡¸· ÃâÇ÷

  • mycolic acid
    ¹ÌÄÝ»ê.
  • N-Benzol-L-tyrosyl-p-aminobenzoic acid
    N-º¥Á¹-L-Ƽ·Î½Ç-p-¾Æ¹Ì³ë ¾È½ÄÇâ»ê
  • nalidixic acid
    ³¯¸®µñ½º»ê
    C
  • naphthalenesulfonic acid
    ³ªÇÁÅ»·» ¼úÆù»ê
    ³ªÇÁÅ»·»À» ¼úÆùÈ­½ÃŰ¸é »ý±â´Â È­ÇÕ¹°. 1-³ªÇÁÅ»·» ¼úÆù»ê°ú 2-³ªÇÁÅ»·» ¼úÆù»êÀÇ µÎ À̼ºÁúü°¡ ÀÖ´Ù. ÀüÀÚ´Â 60 ¡É ÀÌÇÏÀÇ ¹ÝÀÀ ¿Âµµ¿¡¼­ ¾òÀ» ¼ö ÀÖ°í, ÈÄÀÚ´Â 165 ¡É¿¡¼­ ¾òÀ» ¼ö ÀÖ´Ù. ¾ËÄ®¸® À¶ÇØÇÏ¸é ³ªÇÁÅçÀ» ¾ò´Â´Ù. ³ªÇÁÅ»·»À» ¿ø·á·Î ÇÏ´Â ¿°·á´Â ´ëºÎºÐ ³ªÇÁÅ»·» ¼úÆù»êÀ» °ÅÃÄ ÇÕ¼ºµÇ¹Ç·Î ¿°·á °ø¾÷¿¡ ¸Å¿ì Áß¿äÇÏ´Ù. ¸ð³ë ¼úÆù»êÀ» ´Ù½Ã ¼úÆùÈ­Çϸé Á¶°Ç¿¡ µû¶ó ¿©·¯ ¼úÆù»êÀÌ »ý±ä´Ù. ¶Ç ³ªÇÁÅç ¼úÆù»êÀÇ ¾Æ¹Ì³ë À¯µµÃ¼, ³ªÇÁÅç ¼úÆù»ê µîÀÌ ¿°·á Áß°£Ã¼·Î¼­ ¸¹ÀÌ »ý¼ºµÈ´Ù.
  • Newton's method for uric acid
    ´º¿ìư ¿ä»ê Á¤·®¹ý
    »ê¼º ¿°È­Àº ħÀü¹ý¿¡ ÀÇÇØ °£¼· ¹°ÁúÀ» Á¦°ÅÇϰí, û»ê¿°À» È¥ÇÕÇÑ Çǰ˾×À» ºñ¼Ò ÅÖ½ºÅÙ ½Ã¾àÀ» 24½Ã°£ ½Ç¿Â¿¡¼­ ¹ÝÀÀ½ÃÄÑ ºñ»öÇÑ´Ù.
  • Nissl's acid
    ´Ï½½»ê
    »ê¼º¾× ¶Ç´Â ¾Ï¸ð´Ï¾Æ¿¡ ³ì´Â´Ù.
  • nitrobenzoic acid
    ´ÏÆ®·Î ¾È½ÄÇâ »ê
    NO2C6H4COOH. ´ÏÆ®·Î Åç·ç¿ÃÀÌ »êÈ­µÇ¾î »ý±â´Â È­ÇÕ¹°.
  • nitroferrocyanic acid
    ´ÏÆ®·Î Æä·Î½Ã¾È»ê
    H2[Fe
  • octanoic acid
    ¿ÁÅ×Àλê
  • oleic acid
    ¿Ã·¹»ê
    µ¿½Ä¹°¿¡ ³Î¸® Á¸ÀçÇÏ´Â Áö¹æ»ê. È­ÇÐ½Ä C8H4O, ³ì´ÂÁ¡ 12 ¡É, ²ú´ÂÁ¡ 360 ¡ÉÀÌ´Ù. ÀÌÁß °áÇÕÀ» 1°³ °¡Áö´Â ºÒÆ÷È­ Áö¹æ»êÀÌ´Ù. ¹°¿¡´Â °ÅÀÇ ³ìÁö ¾ÊÀ¸³ª, ¿¡Åº¿Ã, ¿¡Å׸£, Ŭ·Î·ÎÆ÷¸§ µî¿¡´Â ³ì´Â´Ù. ¹é±ÝÈæ, ´ÏÄÌ µîÀ» Ã˸ŷΠÇÏ¿© ¼ö¼Ò·Î ȯ¿ø½ÃŰ¸é Æ÷È­ÀÎ ½ºÅ׾Ƹ£»êÀÌ µÈ´Ù. ¼ø¼öÇÑ °ÍÀº ¹«»ö, ¹«ÃëÀÎ À¯»ó ¾×üÀ̳ª, °ø±â ¼Ó¿¡ ¹æÄ¡ÇØ µÎ¸é »êÈ­µÇ¾î Ȳ»ö ¶Ç´Â °¥»öÀ¸·Î Âø»öµÇ°í ½â´Â ³¿»õ°¡ ³­´Ù. µ¿¹°¿¡¼­´Â ±Û¸®¼¼¸°°ú ¿¡½ºÅ׸£¸¦ Çü¼ºÇÏ¿© ÇÇÇÏ Áö¹æÀ̳ª °£¿¡ ÀúÀåµÈ´Ù. °ø¾÷ÀûÀ¸·Î ¿ëµµ°¡ ³ÐÀ¸¸ç, ºñ´©ÀÇ ¿ø·á³ª õÀÇ ¹æ¼öÁ¦·Î¼­ ÀÌ¿ëµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
Fenton reaction The use of H2O2 and ferrous salts (Fenton's reagent) to oxidise alpha-hydroxy acids to alpha-keto acids or to convert 1,2-glycols to alpha-hydroxy aldehydes, the formation of OH-, OH-, and Fe3+ from the nonenzymatic reaction of Fe2+ with H2O2; a reaction of importance in the oxidative stress in blood cells and various tissues.
(05 Mar 2000)
Fernandez reaction A delayed hypersensitivity lepromin reaction, similar to a tuberculin reaction, at the site of intradermal injection of Dharmendra antigen in a lepromin test.
(05 Mar 2000)
ferric chloride reaction of epinephrine An intense emerald green colour in a neutral or slightly acid solution of epinephrine when ferric chloride is added to it; a reaction typical of catechols.
(05 Mar 2000)
Feulgen reaction <procedure> A specific staining procedure for DNA: mild acid hydrolysis makes the aldehyde group of deoxyribose available to react with Schiff's reagent to give a purple colour.
(18 Nov 1997)
fight or flight reaction The theory advanced by Walter Cannon, that in the autonomic nervous system and the effectors connected with it, the organism in situations of danger requiring either fight or flight is provided with a check-and-drive mechanism that puts it in readiness to meet emergencies with undivided energy output. Also known as the emergency theory.
(05 Mar 2000)
first-order reaction A reaction the rate of which is proportional to the concentration of the single substance undergoing change; radioactive decay is a first-order process, defined by the equation -(dN/dt)=kN, where N is the number of atoms subject to decay (reaction), t is time, and k is the first-order decay (reaction) constant, i.e., the fraction of all atoms decaying per unit of time.
See: decay constant, order.
(05 Mar 2000)
fixation reaction <immunology> Binding of complement as a result of its interaction with immune complexes (the classical pathway) or particular surfaces (alternative pathway).
(18 Nov 1997)
flocculation reaction A form of precipitin reaction in which precipitation occurs over a narrow range of antigen-antibody ratio, due chiefly to peculiarities of the antibody (precipitin).
(05 Mar 2000)
focal reaction A reaction which occurs at the point of entrance of an infecting organism or of an injection, as in the Arthus phenomenon.
Synonym: local reaction.
(05 Mar 2000)
Folin's reaction The reaction of amino acids in alkaline solution with 1,2-naphthoquinone-4-sulfonate (Folin's reagent) to yield a red colour; useful for quantitative assay.
Synonym: Folin's reagent.
(05 Mar 2000)
foreign-body reaction Chronic inflammation and granuloma formation around irritating foreign bodies.
(12 Dec 1998)
Forssman antigen-antibody reaction The combination of Forssman antibody with heterogenetic antigen of the Forssman type, as in the agglutination of sheep erythrocytes (which contain Forssman antigen) by serum from a person with infectious mononucleosis which contains Forssman antibody.
Synonym: Forssman reaction.
(05 Mar 2000)
Forssman reaction The combination of Forssman antibody with heterogenetic antigen of the Forssman type, as in the agglutination of sheep erythrocytes (which contain Forssman antigen) by serum from a person with infectious mononucleosis which contains Forssman antibody.
Synonym: Forssman reaction.
(05 Mar 2000)
late reaction A local or generalised response that begins 24 to 48 hours after exposure to an antigen.
See: cell-mediated reaction.
Synonym: contact hypersensitivity, delayed hypersensitivity, late reaction, tuberculin-type hypersensitivity.
(05 Mar 2000)
fragment reaction A reaction used to assay the activity of peptidyl transferase.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á